Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration Ropivacaine 0,2%

What this Trial Is About

Researchers are evaluating whether adding a Transversus Abdominis Plane (TAP) block improves pain control and recovery after cesarean section in women. The study aims to compare postoperative pain scores, opioid use within 24 hours, and quality of recovery between patients receiving the TAP block plus standard care and those receiving the traditional pain management regimen. This trial focuses on postoperative acute pain and the effectiveness of different analgesic strategies after cesarean delivery. Participants are randomly assigned to one of two groups. One group receives an ultrasound-guided TAP block with low concentration ropivacaine (0.2%) at a dose of 0.4 ml/kg per side, performed at the end of surgery under spinal anesthesia, plus postoperative ibuprofen and paracetamol with tramadol as needed. The other group receives the hospital's traditional analgesic regimen including metamizole, NSAIDs, paracetamol, and scheduled tramadol. Pain is managed and assessed using a numeric rating scale, with rescue opioid analgesics given if needed. During the study, participants stay in the obstetric intensive care unit for 12 to 24 hours after surgery before moving to the ward. Pain is measured at rest, during movement, breastfeeding, and walking using the Numeric Rating Scale targeting scores of 4 or less. Opioid consumption is recorded for the first 24 hours. At 24 hours post-surgery, participants complete the ObsQoR-11 questionnaire, which evaluates recovery across physical comfort, independence, emotional state, and pain control. Researchers monitor these outcomes to compare the quality of postoperative recovery and opioid needs between the groups.

Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration Ropivacaine 0,2%